ASCO-CAP guidelines for breast predictive factor testing: an update
- PMID: 22089488
- DOI: 10.1097/PAI.0b013e31822a8eac
ASCO-CAP guidelines for breast predictive factor testing: an update
Abstract
This brief report compares and contrasts the American Society of Clinical Oncology/College of American Pathologists guidelines for breast cancer predictive factor testing including the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor, type 2, erbB2 Guideline published in 2007 and the recently published Guideline for Estrogen Receptor and Progesterone Receptor Testing by Immunohistochemistry, published in 2011.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
